1. Home
  2. RCUS vs KNTK Comparison

RCUS vs KNTK Comparison

Compare RCUS & KNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$19.64

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Kinetik Holdings Inc.

KNTK

Kinetik Holdings Inc.

HOLD

Current Price

$46.87

Market Cap

2.5B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCUS
KNTK
Founded
2015
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Natural Gas Distribution
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.5B
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
RCUS
KNTK
Price
$19.64
$46.87
Analyst Decision
Buy
Buy
Analyst Count
9
11
Target Price
$28.22
$46.45
AVG Volume (30 Days)
913.0K
1.5M
Earning Date
05-28-2026
05-29-2026
Dividend Yield
N/A
7.45%
EPS Growth
N/A
N/A
EPS
N/A
0.41
Revenue
$247,000,000.00
$160,617,000.00
Revenue This Year
N/A
$27.32
Revenue Next Year
N/A
$7.31
P/E Ratio
N/A
$106.12
Revenue Growth
N/A
8.23
52 Week Low
$6.79
$31.33
52 Week High
$26.40
$59.74

Technical Indicators

Market Signals
Indicator
RCUS
KNTK
Relative Strength Index (RSI) 43.81 70.63
Support Level $8.86 $42.85
Resistance Level $21.55 $47.19
Average True Range (ATR) 1.09 2.05
MACD 0.03 0.22
Stochastic Oscillator 36.70 83.20

Price Performance

Historical Comparison
RCUS
KNTK

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About KNTK Kinetik Holdings Inc.

Kinetik Holdings Inc is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines. The company operates in two reportable segments which include The Midstream Logistics segment operates under three service offerings, 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. The Pipeline Transportation segment consists of three EMI pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.

Share on Social Networks: